Fisher’s exact test demonstrated that the relative overexpression EPHA2 and VEGFC in Ewing’s sarcoma was 15- and 17-fold, respectively, when compared to all pediatric cancer and normal samples (P<0.001 for both comparisons) (File S1). This evidence concerns the gene EPHA2 and Ewing sarcoma.